CLINICAL_TRIALS
trial_result
· 2022-12-05
Clinical Trial Update: Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation [Phase 3]
Summary
Phase 3 trial investigating propranolol as an anxiolytic to reduce sedative use in critically ill adults on mechanical ventilation; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ottawa Hospital Research Institute | Conditions: Mechanical Ventilation, Sedation | Phase 3 | Status: COMPLETED